» Articles » PMID: 25901889

Type 2 Diabetes and Gut Microbiome: at the Intersection of Known and Unknown

Overview
Journal Gut Microbes
Date 2015 Apr 23
PMID 25901889
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of metabolic syndrome is increasing rapidly across the globe. Though the prevalence of the disease is similar in population of upper middle income and high income countries, the age of affected population is lower in upper middle income countries. This is attributed to genetic as well as changing life style factors. The contributing factors for type 2 diabetes range from genetic/epigenetic disposal, intra uterine nutrition, dietary pattern to sedentary lifestyle. The role of the gut microbiota in metabolic disorders is increasingly gaining importance. Several studies have reported significant difference in the profile of the gut microbiota in Caucasian population considering obese and type 2 diabetic populations while limited number of studies are available on populations from the developing world. The metabolites from the gut microbes contribute to the gut barrier integrity and a compromised barrier leads to leakage of inflammatory mediators into systemic circulation and hence increases insulin resistance. Attempts have been made at correcting metabolic syndrome through dietary changes by altering the gut microbiota with some success. This report is an attempt to explain the hypothesis of compromised nutrition altering the gut microbiota, gut metabolites, gut barrier function, systemic inflammation and hence insulin response.

Citing Articles

Gut microbiota composition and type 2 diabetes: Are these subjects linked Together?.

Razavi S, Amirmozafari N, Zahedi Bialvaei A, Navab-Moghadam F, Khamseh M, Alaei-Shahmiri F Heliyon. 2024; 10(20):e39464.

PMID: 39469674 PMC: 11513563. DOI: 10.1016/j.heliyon.2024.e39464.


Metagenomic functional profiling: to sketch or not to sketch?.

Hera M, Liu S, Wei W, Rodriguez J, Ma C, Koslicki D Bioinformatics. 2024; 40(Suppl 2):ii165-ii173.

PMID: 39230701 PMC: 11373326. DOI: 10.1093/bioinformatics/btae397.


Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes.

Sasidharan Pillai S, Gagnon C, Foster C, Ashraf A J Clin Endocrinol Metab. 2024; 109(11):2709-2719.

PMID: 39040013 PMC: 11479700. DOI: 10.1210/clinem/dgae499.


Gut microbiota interacts with inflammatory responses in acute pancreatitis.

Wu L, Hu J, Yi X, Lv J, Yao J, Tang W Therap Adv Gastroenterol. 2023; 16:17562848231202133.

PMID: 37829561 PMC: 10566291. DOI: 10.1177/17562848231202133.


Qing-Kai-Ling oral liquid alleviated pneumonia via regulation of intestinal flora and metabolites in rats.

Chen H, Li S, Pan B, Liu K, Yu H, Ma C Front Microbiol. 2023; 14:1194401.

PMID: 37362920 PMC: 10288885. DOI: 10.3389/fmicb.2023.1194401.


References
1.
Kooner J, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P . Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011; 43(10):984-9. PMC: 3773920. DOI: 10.1038/ng.921. View

2.
Cani P, Joly E, Horsmans Y, Delzenne N . Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr. 2005; 60(5):567-72. DOI: 10.1038/sj.ejcn.1602350. View

3.
Yin Y, Yu Q, Fu N, Liu X, Lu F . Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol. 2010; 16(27):3394-401. PMC: 2904885. DOI: 10.3748/wjg.v16.i27.3394. View

4.
Sweeney T, Morton J . The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg. 2013; 148(6):563-9. PMC: 4392891. DOI: 10.1001/jamasurg.2013.5. View

5.
Smith M, Yatsunenko T, Manary M, Trehan I, Mkakosya R, Cheng J . Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013; 339(6119):548-54. PMC: 3667500. DOI: 10.1126/science.1229000. View